美国 · 平台与数据 · The Motley Fool
TG Therapeutics: 3 Key Takeaways for Long-Term Investors

详细摘要
Single-dose IV initiation could remove a second clinic visit, but it remains to be seen whether that convenience translates into demand before 2027.
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.fool.com)


